Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
28/04/2026 14:13
April 28 (Reuters) - Wanbury Ltd WANB.NS: WANBURY LTD - PATALGANGA SITE HAS COMPLETED KOREA FDA REGULATORY INSPECTION SUCCESSFULLY Source text: ID:nBSEcbw68G Further company coverage: WANB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility